Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10131961 | 0.81 | NOS1 (0.51) | CYP19A1MAOBALDH1A1LMNAMAPK1 | |
| SCHEMBL8646446 | 0.79 | HDAC1 (0.57) | CYP19A1MAOBALDH1A1TSHRRAB9A | |
| SCHEMBL28872991 | 0.79 | KMT2A (0.55) | CYP19A1MAOBALDH1A1LMNARAB9A | |
| SCHEMBL12678483 | 0.79 | CYP19A1 (0.60) | CYP19A1MAOBALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL5473408 | 0.78 | MAOB (0.54) | MAOBALDH1A1SMN1; SMN2LMNANPC1 | |
| SCHEMBL6906260 | 0.78 | MEP1B (0.49) | CYP19A1MAOBALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL18095346 | 0.78 | TSHR (0.54) | CYP19A1MAOBTSHRNPC1CYP1A2 | |
| SCHEMBL6911637 | 0.77 | MEP1B (0.55) | CYP19A1MAOBMEP1B | |
| SCHEMBL3335985 | 0.76 | LMNA (0.59) | MAOBALDH1A1LMNAMAPK1MEN1 | |
| SCHEMBL4623980 | 0.75 | TSHR (0.55) | CYP19A1MAOBALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4000609-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | UNIV NAT CHONNAM IND FOUND (KR) | 2024-11-13 | — | — | EP | disclosed |
| US-20220313633-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2022-10-06 | — | — | US | disclosed |
| EP-4000609-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | Industry Foundation of Chonnam National University (KR) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220313633-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | HPGDS, ARG1, RELA | CYP19A1 966/4885MAOB 3180/4885ALDH1A1 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.